logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

美国疾病预防控制中心 冠状病毒测试 PerkinElmer

Healthcare Roundup – Coronavirus testing available in every state, PerkinElmer cuts views due to coronavirus outbreak

Mar 10, 2020

Life Science

中国上海奥浦迈完成1400万美元新一轮融资

Shanghai OPM Bio Raises $14 Million for Biologic CDMO Service Platform

Mar 9, 2020

Life Science

Vasella Numab 融资 癌症 试验

Vasella helps Numab to CHF22M round ahead of cancer trial start

Mar 9, 2020

Life Science

亚盛医药 APG-2575

Ascentage Pharma Announces Clearances for Three Phase Ib/II Clinical Studies of APG-2575 in China and the U.S., Beginning Simultaneous Clinical Development in Three Hematologic Malignancy Indications

Mar 9, 2020

Life Science

Production of Dermal Injectors Delayed by China Work Stoppage Effecting Critical Component

Mar 9, 2020

Life Science

Cocrystal Pharma Gilead COVID-19 coronavirus

Healthcare Roundup – Cocrystal Pharma up 36% after hours on launch of coronavirus program, Gilead up 3% ahead of expected COVID-19 drug data readout

Mar 7, 2020

Life Science

西奈山 和铂医药 癌症 新冠病毒

Mount Sinai and Harbour BioMed Collaborate to Advance Novel Biotherapies for the Treatment of Cancer and Coronavirus COVID-19

Mar 6, 2020

Life Science

腾讯 微医 IPO

Tencent-backed WeDoctor invites banks to lead $1 billion Hong Kong IPO, sources say

Mar 6, 2020

Life Science

信诺 新冠病毒 测试

Healthcare Roundup – Global coronavirus cases approaching 100K, Cigna to waive member fees for coronavirus testing

Mar 6, 2020

Life Science

新冠病毒 生物制药

Coronavirus Stimulates Biopharma and Academia Research Activities and Collaborations

Mar 5, 2020

Life Science

上海挚盟医药 HBV

Shanghai Zhimeng Starts US Phase I Trial of Novel HBV Treatment

Mar 5, 2020

Life Science

再生元 Moderna 冠状病毒 药物 疫苗

Healthcare Roundup – Regeneron expects coronavirus med to be ready by August, Moderna advances coronavirus vaccine candidate into the clinic

Mar 4, 2020

Life Science

罗氏 Actemra 冠状病毒

China approves use of Roche arthritis drug for coronavirus patients

Mar 4, 2020

Life Science

英特尔 联想 华大基因

Intel, Lenovo Help BGI Genomics Speed Up Coronavirus Genome Analysis

Mar 4, 2020

Life Science

美联储 国家灾难计划 冠状病毒 礼来

Healthcare Roundup – Feds mull use of national disaster program for coronavirus care, Coronavirus outbreak to not affect supply of medicines

Mar 3, 2020

Life Science

美国Abpro在亚洲上市免疫肿瘤学和眼科药物

Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody Candidates in Asian Markets

Mar 3, 2020

Life Science

Naturally Splendid Ships Container of Hemp to Southeast Asia

Mar 3, 2020

Life Science

Schrödinger 谷歌 美国 冠状病毒计划

Healthcare Roundup – Schrödinger teams up with Google, U.S. authorities ramp up coronavirus plans

Mar 3, 2020

Life Science

  • ‹‹ Previous
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada